API Consumer Brands

API in New Zealand

In July 2021, API notified the Australian Stock Exchange(external link) that they had decided to focus on their retail and distribution businesses.

What is Pharmac doing

Sponsorship of the API products has largely been transferred to Noumed Pharmaceuticals limited and will continue to be supplied until a new brand enters the market. Noumed began supplying these products on 18 July 2022. 

Pharmac is considering multiple options for products currently supplied by API. We're reviewing each medicine to find the best solution. One of these options is using our annual tender process to find new suppliers for these treatments. We are updating this page with information about what is happening with each product. 

We are working closely with API and other suppliers to ensure as little disruption as possible for people using API's products.

What will happen to my medicine?

Most likely, your medicine will still be available. But you might need to use a different brand. 

If no suppliers are willing to supply your existing medicine, you will need to talk to your doctor about moving to a suitable alternative treatment.

As we find replacements, we’ll let doctors and pharmacists know. We’ll also put information on our website.

We know that changing medicine can be disruptive. We’re working hard to keep this to a minimum. Thank you for your understanding.

Affected products

Products we've found a solution for

The "listing date" is the first day the new brand will be funded. The "principal supply date" is the date that the old brand will no longer be available. 

Products we're still working on

 * Noumed Pharmaceuticals is the sponsor until the new supplier takes over.

Who to contact

If you have questions about this issue, email enquiry@pharmac.govt.nz